-
Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
04 Aug 2025 12:03 GMT
… President of Corporate Development at Millennium Pharmaceuticals, Inc., from 1999 to 2008 …
-
Advanced Merkel Cell Carcinoma Pipeline Outlook Report 2025: Key 20+ Companies And Breakthrough Therapies Shaping The Future Landscape
30 Jul 2025 03:46 GMT
… , Inc., Incyte Corporation, Millennium Pharmaceuticals, Inc., Exelixis, Bristol- … , Inc., Incyte Corporation, Millennium Pharmaceuticals, Inc., Exelixis, Bristol- … Xencor, Inc., Incyte Corporation, Millennium Pharmaceuticals, Inc., Exelixis, Bristol-Myers …
-
Aclaris Therapeutics Announces Leadership Transition
28 Jul 2025 12:45 GMT
… scientific roles at Peptimmune and Millennium Pharmaceuticals. Dr. Kolbeck has published over …
-
Pevonedistat hydrochloride by Millennium Pharmaceuticals for Essential Thrombocythemia: Likelihood of Approval
27 Oct 2023 16:35 GMT
… the below form
By GlobalData
Millennium Pharmaceuticals overview
Millennium Pharmaceuticals (Takeda Oncology), a subsidiary …
-
Ixazomib citrate by Millennium Pharmaceuticals for Lymphoblastic Lymphoma: Likelihood of Approval
27 Oct 2023 16:35 GMT
… and graft versus host disease.
Millennium Pharmaceuticals overview
Millennium Pharmaceuticals (Takeda Oncology), a subsidiary …
-
Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight
15 Jul 2025 17:00 GMT
… Pharma, Five Prime Therapeutics, Inc., Millennium Pharmaceuticals, Inc., Novartis Oncology, Takeda, Mundipharma …
-
Pevonedistat hydrochloride by Millennium Pharmaceuticals for Solid Tumor: Likelihood of Approval
10 Feb 2023 09:11 GMT
… is under clinical development by Millennium Pharmaceuticals and currently in Phase I … refractory acute lymphocytic leukemia.
Millennium Pharmaceuticals overview
Millennium Pharmaceuticals is a biopharmaceutical company that …
-
Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight
14 Jul 2025 17:00 GMT
… .A., Bio-Path Holdings, Inc., Millennium Pharmaceuticals, Inc., Carna Biosciences, Inc., among …
-
MIT and Mass General Hospital researchers find disparities in organ allocation
03 Jul 2025 18:18 GMT
… Inc. (successor in interest to Millennium Pharmaceuticals Inc.), an NIH Ruth L …
-
Non-Small Cell Lung Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, And Pipeline Analysis Glaxosmithkline, Novartis, Astrazeneca, Eli Lilly And Company
27 Jun 2025 00:08 GMT
… . Hoffmann-La Roche Ltd., Merck, Millennium Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc …